[[[(2R,3S,4R,5R)-5-[8-(4-aminophenyl)imidazo[2,1-f]purin-3-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl] phosphate;tetrakis(tributylazanium)

C66H129N10O13P3 — CID 10772787

IUPAC[[[(2R,3S,4R,5R)-5-[8-(4-aminophenyl)imidazo[2,1-f]purin-3-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl] phosphate;tetrakis(tributylazanium)
SMILESCCCC[NH+](CCCC)CCCC.CCCC[NH+](CCCC)CCCC.CCCC[NH+](CCCC)CCCC.CCCC[NH+](CCCC)CCCC.Nc1ccc(-c2cn3cnc4c(ncn4[C@@H]4O[C@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])[C@@H](O)[C@H]4O)c3n2)cc1
InChIInChI=1S/C18H21N6O13P3.4C12H27N/c19-10-3-1-9(2-4-10)11-5-23-7-21-16-13(17(23)22-11)20-8-24(16)18-15(26)14(25)12(35-18)6-34-39(30,31)37-40(32,33)36-38(27,28)29;4*1-4-7-10-13(11-8-5-2)12-9-6-3/h1-5,7-8,12,14-15,18,25-26H,6,19H2,(H,30,31)(H,32,33)(H2,27,28,29);4*4-12H2,1-3H3/t12-,14-,15-,18-;;;;/m1..../s1
InChIKeyMAGQPIBBRKGNIR-LXGAUNIYSA-N
MW1363.74 g/mol
LogP6.85
Rot. Bonds45

About [[[(2R,3S,4R,5R)-5-[8-(4-aminophenyl)imidazo[2,1-f]purin-3-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl] phosphate;tetrakis(tributylazanium)

[[[(2R,3S,4R,5R)-5-[8-(4-aminophenyl)imidazo[2,1-f]purin-3-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl] phosphate;tetrakis(tributylazanium) (PubChem CID 10772787) has the molecular formula C66H129N10O13P3 and a molecular weight of 1363.74 g/mol. Its IUPAC name is [[[(2R,3S,4R,5R)-5-[8-(4-aminophenyl)imidazo[2,1-f]purin-3-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl] phosphate;tetrakis(tributylazanium).

Molecular Properties

Compound Name[[[(2R,3S,4R,5R)-5-[8-(4-aminophenyl)imidazo[2,1-f]purin-3-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl] phosphate;tetrakis(tributylazanium)
PubChem CID10772787
Molecular FormulaC66H129N10O13P3
Molecular Weight1363.74 g/mol
Exact Mass1362.90
IUPAC Name[[[(2R,3S,4R,5R)-5-[8-(4-aminophenyl)imidazo[2,1-f]purin-3-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl] phosphate;tetrakis(tributylazanium)
SMILESCCCC[NH+](CCCC)CCCC.CCCC[NH+](CCCC)CCCC.CCCC[NH+](CCCC)CCCC.CCCC[NH+](CCCC)CCCC.Nc1ccc(-c2cn3cnc4c(ncn4[C@@H]4O[C@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])[C@@H](O)[C@H]4O)c3n2)cc1
InChIInChI=1S/C18H21N6O13P3.4C12H27N/c19-10-3-1-9(2-4-10)11-5-23-7-21-16-13(17(23)22-11)20-8-24(16)18-15(26)14(25)12(35-18)6-34-39(30,31)37-40(32,33)36-38(27,28)29;4*1-4-7-10-13(11-8-5-2)12-9-6-3/h1-5,7-8,12,14-15,18,25-26H,6,19H2,(H,30,31)(H,32,33)(H2,27,28,29);4*4-12H2,1-3H3/t12-,14-,15-,18-;;;;/m1..../s1
InChIKeyMAGQPIBBRKGNIR-LXGAUNIYSA-N
XLogP6.85
TPSA312.62 Ų
H-Bond Donors7
H-Bond Acceptors19
Rotatable Bonds45
Heavy Atoms92
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001363.74
LogP ≤ 56.85
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1019

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aniline', 'substructure': 'N/A'}, {'alert_name': 'phosphor', 'substructure': 'N/A'}

Analyze [[[(2R,3S,4R,5R)-5-[8-(4-aminophenyl)imidazo[2,1-f]purin-3-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl] phosphate;tetrakis(tributylazanium) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [[[(2R,3S,4R,5R)-5-[8-(4-aminophenyl)imidazo[2,1-f]purin-3-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl] phosphate;tetrakis(tributylazanium)?
The IUPAC name of [[[(2R,3S,4R,5R)-5-[8-(4-aminophenyl)imidazo[2,1-f]purin-3-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl] phosphate;tetrakis(tributylazanium) (CID 10772787) is [[[(2R,3S,4R,5R)-5-[8-(4-aminophenyl)imidazo[2,1-f]purin-3-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl] phosphate;tetrakis(tributylazanium).
What is the SMILES notation for [[[(2R,3S,4R,5R)-5-[8-(4-aminophenyl)imidazo[2,1-f]purin-3-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl] phosphate;tetrakis(tributylazanium)?
The canonical SMILES for [[[(2R,3S,4R,5R)-5-[8-(4-aminophenyl)imidazo[2,1-f]purin-3-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl] phosphate;tetrakis(tributylazanium) is CCCC[NH+](CCCC)CCCC.CCCC[NH+](CCCC)CCCC.CCCC[NH+](CCCC)CCCC.CCCC[NH+](CCCC)CCCC.Nc1ccc(-c2cn3cnc4c(ncn4[C@@H]4O[C@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])[C@@H](O)[C@H]4O)c3n2)cc1.
What is the InChIKey of [[[(2R,3S,4R,5R)-5-[8-(4-aminophenyl)imidazo[2,1-f]purin-3-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl] phosphate;tetrakis(tributylazanium)?
The InChIKey is MAGQPIBBRKGNIR-LXGAUNIYSA-N. The full InChI is InChI=1S/C18H21N6O13P3.4C12H27N/c19-10-3-1-9(2-4-10)11-5-23-7-21-16-13(17(23)22-11)20-8-24(16)18-15(26)14(25)12(35-18)6-34-39(30,31)37-40(32,33)36-38(27,28)29;4*1-4-7-10-13(11-8-5-2)12-9-6-3/h1-5,7-8,12,14-15,18,25-26H,6,19H2,(H,30,31)(H,32,33)(H2,27,28,29);4*4-12H2,1-3H3/t12-,14-,15-,18-;;;;/m1..../s1.
What are the key properties of [[[(2R,3S,4R,5R)-5-[8-(4-aminophenyl)imidazo[2,1-f]purin-3-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl] phosphate;tetrakis(tributylazanium)?
[[[(2R,3S,4R,5R)-5-[8-(4-aminophenyl)imidazo[2,1-f]purin-3-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl] phosphate;tetrakis(tributylazanium) has a molecular weight of 1363.74 g/mol, XLogP of 6.85, 45 rotatable bonds, 7 hydrogen bond donors, and 19 hydrogen bond acceptors.
Where does this data come from?
All data for [[[(2R,3S,4R,5R)-5-[8-(4-aminophenyl)imidazo[2,1-f]purin-3-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl] phosphate;tetrakis(tributylazanium) is sourced from PubChem (CID 10772787), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).